PAMA
HHS Report Finds Medicare Lab Spending Dropped 5 Percent in 2023 on Lower COVID-19 Volumes
The report also indicates that while PAMA has cut spending on routine tests, overall lab spending has risen as genetic testing continues to grow.
While Congress has protected labs from PAMA cuts via a series of one-year delays, this has locked lab prices at 2016 levels, heightening the urgency for a permanent fix.
Top Five Articles on 360Dx Last Week: Digital Pathology Adoption; FDA Reclassify Hep B Tests; More
Last week, readers were most interested in a story about whether digital pathology is approaching a breakout moment in its adoption curve.
Congress Passes One-Year Delay to PAMA Implementation … Again
Lab test reimbursement cuts and price reporting requirements that were called for under the law will be delayed as part of the recently passed spending bill.
The organization's priorities also include developing appropriate pediatric reference intervals for diagnostic tests.
Jul 23, 2024
Apr 8, 2024
Oct 24, 2023
Oct 24, 2023
Jul 25, 2023
Dec 21, 2022
Dec 15, 2022
Oct 20, 2022
Jul 24, 2022